CRWV insider plans Rule 144 sale of 32,455 shares

CRWV insider activity shows a planned Rule 144 sale of 32,455 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $3,086,795.05, on or about February 11, 2026 on NASDAQ.

Accepted by SEC EDGAR 02/11/2026 - 04:30 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

CRWV insider activity shows a planned Rule 144 sale of 32,455 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $3,086,795.05, on or about February 11, 2026 on NASDAQ.

The seller acquired these 32,455 shares as founder shares on November 13, 2017. Recent activity also includes multiple 10b5-1 plan sales by Michael Intrator and Omnadora Capital LLC over the prior three months, each involving blocks of common stock with multi‑million dollar gross proceeds.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CRWV Rule 144 notice disclose about upcoming share sales?

The notice discloses a planned sale of 32,455 CRWV common shares under Rule 144. These shares, valued at $3,086,795.05, are expected to be sold around February 11, 2026 on NASDAQ through Morgan Stanley Smith Barney’s Executive Financial Services group.

How many CRWV shares are planned to be sold and at what market value?

The planned transaction covers 32,455 CRWV common shares with an aggregate market value of $3,086,795.05. This figure reflects the market value associated with the intended Rule 144 sale arranged through Morgan Stanley Smith Barney’s Executive Financial Services unit.

Who is the broker handling the CRWV Rule 144 stock sale?

Morgan Stanley Smith Barney LLC Executive Financial Services is handling the CRWV Rule 144 sale. The shares are to be sold on NASDAQ, with 32,455 common shares designated in the notice, reflecting a multi‑million‑dollar transaction size based on the stated market value.

When and how were the CRWV shares to be sold originally acquired?

The 32,455 CRWV shares to be sold were acquired on November 13, 2017 as founder shares from the issuer. The notice records the acquisition date, characterizes them as founder shares, and lists the same date for acquisition and payment, with the nature of payment noted as N/A.

What recent 10b5-1 plan sales related to CRWV are disclosed?

The document lists multiple 10b5-1 sales of CRWV common stock over the past three months. Examples include Michael Intrator selling 32,456 shares on January 28, 2026 for $3,443,055.81 and Omnadora Capital LLC selling 50,000 shares the same day for $5,304,190.00 in gross proceeds.

How many CRWV shares are shown as outstanding in this notice?

The notice states that 386,401,201 CRWV common shares are outstanding. This figure provides context for the size of the planned 32,455‑share Rule 144 sale relative to the issuer’s total outstanding common stock base at the time of the notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002058037
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	COREWEAVE INC
SEC File Number	001-42563
Address of Issuer	290 W Mt. Pleasant Ave. Suite 4100 Livingston NEW JERSEY 07039
Phone	9732709737
Name of Person for Whose Account the Securities are To Be Sold	MICHAEL INTRATOR
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	32455	3086795.05	386401201	02/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2017	Founders Shares	Issuer			32455	11/13/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/28/2026	32456	3443055.81
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/28/2026	50000	5304190.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/14/2026	32455	2901243.32
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/14/2026	50000	4469640.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/06/2026	61386	4674746.47
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/31/2025	32456	2334725.61
MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/31/2025	78971	5731033.94
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/31/2025	50000	3596755.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/17/2025	32455	2124981.39
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/17/2025	50000	3273735.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/03/2025	32455	2495279.96
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/03/2025	50000	3844215.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/19/2025	32455	2424654.63
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/19/2025	50000	3735410.00
Non-Affiliate Donee 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/14/2025	75000	5946097.50

144: Remarks and Signature

Remarks
Date of Notice	02/11/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/23/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Michael Intrator
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)